Dr. George Shapiro | Source | Chief Medical Officer at Organicell Regenerative Medicine
Dr. George Shapiro
Chief Medical Officer at Organicell Regenerative Medicine
Link:
Employment
Sign up to view all
-
Organicell Regenerative Medicine
Chief Medical Officer
Media
Sign up to view all
-
Three New COVID-19 Patients Treated with Zofin™ Report Improvement
Organicell announces three new COVID-19 patients treated with Zofin report improvement. Organicell commences Phase I/II clinical trial enrollment.
Article
Recent Quotes
Sign up to view all
-
The six outpatients with different stages of COVID-19 were treated with Zofin under an emergency investigational new drug expanded access program, with physicians for all six patients reporting significant improvement.
